Global Monkeypox Virus Vaccine Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Monkeypox Virus Vaccine Market Insights, Forecast to 2034
Global Monkeypox Virus Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Monkeypox Virus Vaccine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Monkeypox Virus Vaccine key manufacturers include Bavarian Nordic, Sanofi Pasteur Biologics, KM Biologics and Yatai Group, etc. Bavarian Nordic, Sanofi Pasteur Biologics, KM Biologics are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Monkeypox Virus Vaccine were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Monkeypox Virus Vaccine market and estimated to attract more attentions from industry insiders and investors.
Monkeypox Virus Vaccine can be divided into MVA-BN, LC16 and OrthopoxVac,, etc. MVA-BN is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Monkeypox Virus Vaccine is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Monkeypox Virus Vaccine industry development. In 2022, global % sales of Monkeypox Virus Vaccine went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Monkeypox Virus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Monkeypox Virus Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Bavarian Nordic
Sanofi Pasteur Biologics
KM Biologics
Yatai Group
Segment by Type
MVA-BN
LC16
OrthopoxVac
Hospital
Clinic
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Monkeypox Virus Vaccine plant distribution, commercial date of Monkeypox Virus Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Monkeypox Virus Vaccine introduction, etc. Monkeypox Virus Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Monkeypox Virus Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Globally, Monkeypox Virus Vaccine key manufacturers include Bavarian Nordic, Sanofi Pasteur Biologics, KM Biologics and Yatai Group, etc. Bavarian Nordic, Sanofi Pasteur Biologics, KM Biologics are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Monkeypox Virus Vaccine were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Monkeypox Virus Vaccine market and estimated to attract more attentions from industry insiders and investors.
Monkeypox Virus Vaccine can be divided into MVA-BN, LC16 and OrthopoxVac,, etc. MVA-BN is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Monkeypox Virus Vaccine is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Monkeypox Virus Vaccine industry development. In 2022, global % sales of Monkeypox Virus Vaccine went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Monkeypox Virus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Monkeypox Virus Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bavarian Nordic
Sanofi Pasteur Biologics
KM Biologics
Yatai Group
Segment by Type
MVA-BN
LC16
OrthopoxVac
Segment by Application
Hospital
Clinic
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Monkeypox Virus Vaccine plant distribution, commercial date of Monkeypox Virus Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Monkeypox Virus Vaccine introduction, etc. Monkeypox Virus Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Monkeypox Virus Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices